Description du livre Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This monograph gathers and evaluates data on adverse events (AEs) associated specifically with those 'biomedicines' - monoclonal antibodies, fusion proteins, and cytokines - that have recently entered therapeutic use in humans. All AEs observed when using each member of this new drug class are covered, with a view to improving understanding of pathogenesis, facilitating prevention, monitoring, and control, and contributing to the development of better drugs that provide benefits while minimizing risk. Further aspects here examined include the role of drug mechanisms of action and immunogenicity in relation to AEs outcome and induction of systemic syndromes. Additional data on AEs in off-label treatments are also considered.Electronic data sheets, downloadable from Springer Extra Materials platform, include more detailed safety data as well as additional basic information on product characteristics, pre- and post-marketing AEs classified according to frequency, and system/organ targeting. Data on excipients and selected information on drug interactions and associations are also provided. Adverse Events with Biomedicines: Prevention Through Understanding will serve as a detailed, practical guideline to this important new area, which demands the attention of clinicians, immunologists, oncologists, allergologists, public health professionals, and drug companies. 664 pp. Englisch. N� de r�f. du vendeur 9788847058484

Plus d'informations sur ce vendeur | Contacter le vendeur

Acheter neuf

EUR 213,99

Autre devise

Ajouter au panier

Frais de port : EUR 23

De Allemagne vers Etats-Unis

Destinations, frais et d�lais

Image d'archives

Adverse Events with Biomedicines : Prevention Through Understanding

Giuseppe Tridente

Edit� par Springer (2017)

ISBN 10 : 8847058481 ISBN 13 : 9788847058484

Neuf Couverture souple Quantit� disponible : > 20

impression � la demande

Vendeur :

Ria Christie Collections
(Uxbridge, Royaume-Uni)

Evaluation vendeur

Evaluation du vendeur :

Description du livre Etat : New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. N� de r�f. du vendeur ria9788847058484_lsuk

Plus d'informations sur ce vendeur | Contacter le vendeur

Acheter neuf

EUR 226,63

Autre devise

Ajouter au panier

Frais de port : EUR 11,65

De Royaume-Uni vers Etats-Unis

Destinations, frais et d�lais

Image fournie par le vendeur

Adverse Events with Biomedicines : Prevention Through Understanding

Giuseppe Tridente

Edit� par Springer Milan (2017)

ISBN 10 : 8847058481 ISBN 13 : 9788847058484

Neuf Taschenbuch Quantit� disponible : 1

Vendeur :

AHA-BUCH GmbH
(Einbeck, Allemagne)

Evaluation vendeur

Evaluation du vendeur :

Description du livre Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - This monograph gathers and evaluates data on adverse events (AEs) associated specifically with those 'biomedicines' - monoclonal antibodies, fusion proteins, and cytokines - that have recently entered therapeutic use in humans. All AEs observed when using each member of this new drug class are covered, with a view to improving understanding of pathogenesis, facilitating prevention, monitoring, and control, and contributing to the development of better drugs that provide benefits while minimizing risk. Further aspects here examined include the role of drug mechanisms of action and immunogenicity in relation to AEs outcome and induction of systemic syndromes. Additional data on AEs in off-label treatments are also considered.Electronic data sheets, downloadable from Springer Extra Materials platform, include more detailed safety data as well as additional basic information on product characteristics, pre- and post-marketing AEs classified according to frequency, and system/organ targeting. Data on excipients and selected information on drug interactions and associations are also provided. Adverse Events with Biomedicines: Prevention Through Understanding will serve as a detailed, practical guideline to this important new area, which demands the attention of clinicians, immunologists, oncologists, allergologists, public health professionals, and drug companies. N� de r�f. du vendeur 9788847058484

Plus d'informations sur ce vendeur | Contacter le vendeur

Acheter neuf

EUR 217,79

Autre devise

Ajouter au panier

Frais de port : EUR 32,99

De Allemagne vers Etats-Unis

Destinations, frais et d�lais

Image d'archives